Varenicline administration for smoking cessation may reduce apnea hypnea index in sleep apnea patients

A. Pataka (Thessaloniki, Greece), C. Frantzidis (Thessaloniki, Greece), P. Gkivogkli (Thessaloniki, Greece), C. Nday (Thessaloniki, Greece), P. Chriskos (Thessaloniki, Greece), M. Karagianni (Thessaloniki, Greece), H. Styliadis (Thessaloniki, Greece), E. Paraskevopoulos (Nicosia, Cyprus), C. Kourtidou-Papadeli (Thessaloniki, Greece), P. Bamidis (Thessaloniki, Greece)

Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing
Session: Advances in therapeutic plans for sleep disordered breathing
Session type: E-poster
Number: 751

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Pataka (Thessaloniki, Greece), C. Frantzidis (Thessaloniki, Greece), P. Gkivogkli (Thessaloniki, Greece), C. Nday (Thessaloniki, Greece), P. Chriskos (Thessaloniki, Greece), M. Karagianni (Thessaloniki, Greece), H. Styliadis (Thessaloniki, Greece), E. Paraskevopoulos (Nicosia, Cyprus), C. Kourtidou-Papadeli (Thessaloniki, Greece), P. Bamidis (Thessaloniki, Greece). Varenicline administration for smoking cessation may reduce apnea hypnea index in sleep apnea patients. 751

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Severe obstructive sleep apnea patients and smoking cessation
Source: Annual Congress 2009 - Clinical aspects of sleep apnoea
Year: 2009


Tobacco smoking and the severity of obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2005 - What should we know about our SAS patients
Year: 2005


Cigarette smoking behavior and respiratory alterations during sleep in patients with sleep apnea syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 198s
Year: 2006

Cigarette smoking in patients with obstructive sleep apnoea (OSA)
Source: Annual Congress 2010 - Sleep disorders: neurology, smoking and daytime sleepiness
Year: 2010

Reported but not measured sleep latency predicts successful CPAP therapy in patients with obstructive sleep apnoea
Source: Eur Respir J 2002; 20: Suppl. 38, 101s
Year: 2002

The influence of active and former smoking on the amount and quality of sleep in an obstructive sleep apnea (OSA) population versus habitual snorers
Source: Annual Congress 2012 - Tobacco comorbidity
Year: 2012


Return of sleep apnoea and sleep fragmentation following CPAP withdrawal in patients with obstructive sleep apnoea
Source: Eur Respir J, 53 (5) 1802351; 10.1183/13993003.02351-2018
Year: 2019



Effect of smoking on obstructive sleep apnoea (OSA)
Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders
Year: 2007


Insomnia related to sleep apnoea: effect of long-term auto-adjusting positive airway pressure treatment
Source: Eur Respir J 2013; 41: 593-600
Year: 2013



The use of beta-blockers is not associated with increased daytime sleepiness in patients with obstructive sleep apnoea
Source: International Congress 2019 – Beyond continuous positive airway pressure treatment
Year: 2019

Targeted hypoglossal neurostimulation for obstructive sleep apnoea: a 1-year pilot study
Source: Eur Respir J 2013; 41: 360-367
Year: 2013



Wrist-actigraphic estimation of sleep time under nCPAP treatment in sleep apnoea patients
Source: Eur Respir J 2004; 23: 891-895
Year: 2004



Effects of a lifestyle intervention in obese obstructive sleep apnoea patients treated with CPAP
Source: Annual Congress 2012 - Sleep apnoea: clinical topics
Year: 2012


Quitting smoking in sleep apnoea patients: perceived barriers
Source: Annual Congress 2007 - Smoking cessation
Year: 2007


The impact of smoking status on obstructive sleep apnea (OSA) severity.
Source: International Congress 2018 – Sleep and breathing control: phenotypes
Year: 2018

Ato-oxy as the first successful pharmacotherapy for obstructive sleep apnoea
Source: International Congress 2019 – New horizons for pharmacotherapy of sleep-disordered breathing: from bench to bedside
Year: 2019


Differences in age of sleep apnea patients with normalized and persistent excessive daytime sleepiness after nCPAP therapy
Source: Annual Congress 2004 - CPAP therapy for OSA
Year: 2004


Weight change with treatment of obstructive sleep apnea
Source: Annual Congress 2010 - Obesity: positive effects of bariatric surgery and exercise
Year: 2010

Prolonged symptoms and sleep quality after hospitalization for covid-19 in patients with obstructive sleep apnoea
Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing
Year: 2021